late-stage trials

Oncology

Biotech must build manufacturing and trial models that make cell therapies scalable, accessible & commercially viable.

Market Access

At BIO-Europe, the session “From Roasts to Billions: Biopharma Investment Landscape” brought together leading voices from investment banking & VC.

Oncology

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.